Abstract 2126P
Background
The beneficial effects of exercise for cancer patients are well recognized but implemented exercise programs remain scarce, especially for patients during medical treatment. For that reason, we developed a supervised, personalized exercise concept for cancer patients, implemented into a clinical, oncological setting.
Methods
Cancer patients before, during or eventually after their medical treatment with an identified need for exercise could participate in a free of charge exercise intervention for at least three months at the University Hospital Cologne, Germany. We recorded demographic and medical data at enrolment and exercise adherence up to one year.
Results
A sample of n=1.660 patients attended the exercise program. The majority of patients were female (70%), under medical treatment (65%), diagnosed with breast cancer (40%), without metastasis or severe comorbidities (>70%) and on average 54 years old. The median time between diagnosis and exercise participation differed in patients during medical treatment (4 months), patients with metastasis (7 months) and cancer survivors (11 months). Almost one third (31%) discontinued exercise within the first two weeks of participation. Prolonged exercise (median: 19 weeks) was achieved by one third (32%) of the patients. The average exercise adherence was ∼1 session a week with <3% of patients reaching ≥2 sessions a week
Conclusions
To our knowledge, this is the worlds-first report of a professional, supervised exercise program tailored for cancer patients under medical treatment implemented into a clinical setting with >1.600 patients. We described the population that was referred to an exercise program, identified barriers to exercise participation and observed an important mismatch between recommendations and real-world exercise data. Exercise participation was engaged ≥4months after diagnosis and only a third of the patients exercised longer than three months. Almost all patients undercut the well-established exercise recommendations of ≥2 sessions a week. Future implementation concepts should optimize exercise initiation timely after diagnosis and adherence levels due to innovative exercise approaches.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
University Hospital of Cologne, Cologne, Germany.
Funding
German Cancer Aid.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2045P - Patient Reported Outcome Measures (PROMs) capturing therapy adherence of cancer patients: A systematic literature review
Presenter: Luise Richter
Session: Poster session 06
2046P - The importance of communicating bad news in medical education
Presenter: Georgios Goumas
Session: Poster session 06
2047P - Neutrop: A descriptive, observational study for G-CSF prescription in daily practice
Presenter: Florian Scotté
Session: Poster session 06
2048P - Frequency and clinical relevance of drug-drug interactions with oxycodone among patients with cancer
Presenter: Lotte Hulskotte
Session: Poster session 06
2049P - Osimertinib-related muscle cramps as a common adverse event: A real-world data analysis in the post-approval setting
Presenter: Gisele Moreira
Session: Poster session 06
2050P - Integrating ayurveda herbs with standard of care for management of cancer or cancer treatment related anorexia
Presenter: Yogesh Bendale
Session: Poster session 06
2051P - E-PRO within comprehensive companion program for patients undergoing systemic cancer treatment to reduce emergency visits and inpatient admission in a Peruvian institution
Presenter: Patricia Rioja Viera
Session: Poster session 06
2052P - Adverse events in FLOT chemotherapy for locally advanced gastric cancer: An observational study of pre- and post-operative toxicity profiles
Presenter: Camila Oliveira
Session: Poster session 06
2053P - Dehospitalization through outpatient drug release in clinical pharmacy as a strategic cost-minimization action in a public oncology hospital in the Eastern Amazon: A quantitative analysis
Presenter: Kalysta Borges
Session: Poster session 06
2054P - Metastatic cancer patients hospitalized at initial diagnosis: When does rescue systemic therapy make sense? ONIRIS - A national, prospective study
Presenter: Colin Vercueil
Session: Poster session 06